title: Modeling cancer-immune responses to therapy.
abstract: Cancer therapies that harness the actions of the immune response, such as targeted monoclonal antibody treatments and therapeutic vaccines, are relatively new and promising in the landscape of cancer treatment options. Mathematical modeling and simulation of immune-modifying therapies can help to offset the costs of drug discovery and development, and encourage progress toward new immunotherapies. Despite advances in cancer immunology research, questions such as how the immune system interacts with a growing tumor, and which components of the immune system play significant roles in responding to immunotherapy are still not well understood. Mathematical modeling and simulation are powerful tools that provide an analytical framework in which to address such questions. A quantitative understanding of the kinetics of the immune response to treatment is crucial in designing treatment strategies, such as dosing, timing, and predicting the response to a specific treatment. These models can be used both descriptively and predictively. In this chapter, various mathematical models that address different cancer treatments, including cytotoxic chemotherapy, immunotherapy, and combinations of both treatments, are presented. The aim of this chapter is to highlight the importance of mathematical modeling and simulation in the design of immunotherapy protocols for cancer treatment. The results demonstrate the power of these approaches in explaining determinants that are fundamental to cancer-immune dynamics, therapeutic success, and the development of efficient therapies.
authors.affiliation: Department of Mathematics, Harvey Mudd College, Claremont, CA, USA, depillis@hmc.edu.
authors.forename: L G
authors.initials: LG
authors.lastname: dePillis
authors.forename: A
authors.initials: A
authors.lastname: Eladdadi
authors.forename: A E
authors.initials: AE
authors.lastname: Radunskaya
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use*; D003198:Computer Simulation; D003603:Cytotoxins / Q000276:immunology* / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D018448:Models, Immunological; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D003603:Cytotoxins